Christopher Yates MD

Dr. Christopher Yates has over ten years experience in Emergency Medicine and Clinical Toxicology, working at Son Espases Hospital Universitari in Palma de Mallorca, Spain, a tertiary care centre with a high volume of recreational drug use. His special interests lie in emergencies due to recreational drugs of abuse, increasing trends in novel psychoactive substances (NPS), and the use of the ECG and extracorporeal treatments in poisoning.

He has participated as part of the steering group in a European Commission financed project, Euro-DEN Plus, which collects data on recreational drug toxicity aimed among other things at capturing trends in novel drug use. He is involved in a pilot study with the clinical laboratory in the identification of NPS in recreational drug toxicity treated in Son Espases, as well as the other Balearic Islands (Ibiza, Menorca and Formentera).

He has been invited as an expert consultant related to NPS to the EMCDDA NPS Health Response meeting, to the United Nation’s Office of Drug and Crime and to TAIEX conferences in Croatia and the Republic of Georgia. He has also coauthored a chapter (Cocaine) in the second edition of Critical Care Toxicology and several peer-reviewed publications on the subject of NPS and other areas of toxicology as well as given lectures at international, national and local levels and is a member of the Board and Scientific Committee of the European Association of Poison Centres and Clinical Toxicologists (EAPCCT).